Statistically significant is the number of resignations from the sales department due to the leadership of Rohit, Kim & Tim. Now the question is how many people in medical affairs should resign for screwing up the study design in the randomized controlled trials? The stuff works but yet poor study design has cost us more than half our stock and our future outlook. With the upcoming all hands on deck call perhaps a few hands in upper management shouldn’t be holding on any more …
Sincerely,
concern stockholder and employee
Sincerely,
concern stockholder and employee